Tonix Pharmaceuticals Revenue

Pharmaceutical Manufacturing • Chatham, New Jersey, United States • 101-200 Employees

Tonix Pharmaceuticals revenue & valuation

Annual revenue	$9,831,000
Revenue per employee	$76,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$31,500,000
Total funding	$42,900,000

Key Contact at Tonix Pharmaceuticals

Seth Lederman

CEO

Mobile @tonixpharma.com

Company overview

Headquarters	26 Main St, Suite 101, Chatham, New Jersey 07928, US
Phone number	+18627998599
Website	tonixpharma.com
NAICS	3254
SIC	873
Founded	2007
Employees	101-200
Socials

Tonix Pharmaceuticals Email Formats

Tonix Pharmaceuticals uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@tonixpharma.com), used 57.4% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@tonixpharma.com	57.4%
{first name}.{last name}	john.doe@tonixpharma.com	42.6%

About Tonix Pharmaceuticals

Tonix is a biopharmaceutical company, publicly traded on NASDAQ (ticker: TNXP). The Company is focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease. Tonix markets Zembrace® SymTouch® (sumatriptan injection) 3 mg and Tosymra® (sumatriptan nasal spray) 10 mg. Zembrace SymTouch and Tosymra are each indicated for the treatment of acute migraine with or without aura in adults. Tonix’s development portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonix’s CNS development portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. The Company’s immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer. Tonix’s infectious disease pipeline consists of a vaccine in development to prevent smallpox and monkeypox, which also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Director

Manager

Entry

Employees by Department

Tonix Pharmaceuticals has 67 employees across 14 departments.

Departments

Number of employees

Funding Data

Explore Tonix Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-10-28	14	$4,500,000
2024-01-20	14	$30,000,000
2024-04-28	14	$4,400,000
2024-07-12	14	$4,000,000
2025-04-10	9	N/A

Funding Insights

$42,900,000

Total funding amount

Number of funding rounds

Tonix Pharmaceuticals Tech Stack

Discover the technologies and tools that power Tonix Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Underscore.js

JavaScript libraries

Site Kit

Analytics

Animate.css

UI frameworks

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Google Tag Manager

Tag managers

Frequently asked questions

Tonix Pharmaceuticals is located in Chatham, New Jersey, US.

You can reach Tonix Pharmaceuticals at +18627998599.

Tonix Pharmaceuticals generates an estimated annual revenue of $9,831,000. This revenue figure reflects the company's market position and business performance in its industry.

Tonix Pharmaceuticals has an estimated valuation of $31,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Tonix Pharmaceuticals was founded in 2007, making it 19 years old. The company has established itself as a significant player in its industry over this time.

Tonix Pharmaceuticals has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Tonix Pharmaceuticals has raised a total of $42,900,000 across 5 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Tonix Pharmaceuticals

Seth Lederman

CEO

Mobile @tonixpharma.com

4.8

40,000 users